Paper41892479
Molecular Characterization of Colistin-Resistant Clinical Acinetobacter baumannii from Northern Greece: Phenotypic Colistin Susceptibility and lpx/pmrCAB Mutational Profiles.
Karakalpakidis D and 7 others. Antibiotics (Basel), 2026. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. Molecular Characterization of Colistin-Resistant Clinical Acinetobacter baumannii from Northern Greece: Phenotypic Colistin Susceptibility and lpx/pmrCAB Mutational Profiles. Papers, record 41892479. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41892479
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Molecular Characterization of Colistin-Resistant Clinical Acinetobacter baumannii from Northern Greece: Phenotypic Colistin Susceptibility and lpx/pmrCAB Mutational Profiles.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References45
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 29914966 | Colistin Heteroresistance and Involvement of the PmrAB Regulatory System in Acinetobacter baumannii. | Antimicrob Agents Chemother | 2018 | https://conductscience.org/library/papers/29914966 | PubMed |
| 2 | 40872240 | When the Last Line Fails: Characterization of Colistin-Resistant Acinetobacter baumannii Reveals High Virulence and Limited Clonal Dissemination in Greek Hospitals. | Pathogens | 2025 | https://conductscience.org/library/papers/40872240 | PubMed |
| 3 | 23587960 | RND-type efflux pumps in multidrug-resistant clinical isolates of Acinetobacter baumannii: major role for AdeABC overexpression and AdeRS mutations. | Antimicrob Agents Chemother | 2013 | https://conductscience.org/library/papers/23587960 | PubMed |
| 4 | 33466515 | Susceptibility Testing of Colistin for Acinetobacter baumannii: How Far Are We from the Truth? | Antibiotics (Basel) | 2021 | https://conductscience.org/library/papers/33466515 | PubMed |
| 5 | 38214512 | Genomic investigation unveils colistin resistance mechanism in carbapenem-resistant Acinetobacter baumannii clinical isolates. | Microbiol Spectr | 2024 | https://conductscience.org/library/papers/38214512 | PubMed |
| 6 | 35065702 | Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. | Lancet | 2022 | https://conductscience.org/library/papers/35065702 | PubMed |
| 7 | 33007498 | PmrB mutations including a novel 10-amino acid repeat sequence insertion associated with low-level colistin resistance in carbapenem-resistant Acinetobacter baumannii. | Infect Genet Evol | 2020 | https://conductscience.org/library/papers/33007498 | PubMed |
| 8 | 32677578 | A systematic review of implications, mechanisms, and stability of in vivo emergent resistance to colistin and tigecycline in Acinetobacter baumannii. | J Chemother | 2021 | https://conductscience.org/library/papers/32677578 | PubMed |
| 9 | 36978383 | Colistin Resistance in Acinetobacter baumannii: Molecular Mechanisms and Epidemiology. | Antibiotics (Basel) | 2023 | https://conductscience.org/library/papers/36978383 | PubMed |
| 10 | 39908088 | Whole-genome sequencing of Acinetobacter baumannii clinical isolates from a tertiary hospital in Terengganu, Malaysia (2011-2020), revealed the predominance of the Global Clone 2 lineage. | Microb Genom | 2025 | https://conductscience.org/library/papers/39908088 | PubMed |
| 11 | 16145081 | Development of a multilocus sequence typing scheme for characterization of clinical isolates of Acinetobacter baumannii. | J Clin Microbiol | 2005 | https://conductscience.org/library/papers/16145081 | PubMed |
| 12 | 24189257 | Biological cost of different mechanisms of colistin resistance and their impact on virulence in Acinetobacter baumannii. | Antimicrob Agents Chemother | 2014 | https://conductscience.org/library/papers/24189257 | PubMed |
| 13 | 26653099 | Rapid dissemination of colistin and carbapenem resistant Acinetobacter baumannii in Central Greece: mechanisms of resistance, molecular identification and epidemiological data. | BMC Infect Dis | 2015 | https://conductscience.org/library/papers/26653099 | PubMed |
| 14 | 32762604 | Colistin Resistance in Environmental Isolates of Acinetobacter baumannii. | Microb Drug Resist | 2021 | https://conductscience.org/library/papers/32762604 | PubMed |
| 15 | 37600939 | Retained colistin susceptibility in clinical Acinetobacter baumannii isolates with multiple mutations in pmrCAB and lpxACD operons. | Front Cell Infect Microbiol | 2023 | https://conductscience.org/library/papers/37600939 | PubMed |
| 16 | 33364795 | Molecular Characterization of Carbapenem/Colistin-Resistant Acinetobacter baumannii Clinical Isolates from Egypt by Whole-Genome Sequencing. | Infect Drug Resist | 2020 | https://conductscience.org/library/papers/33364795 | PubMed |
| 17 | 30541939 | Antimicrobial Susceptibility Testing for Polymyxins: Challenges, Issues, and Recommendations. | J Clin Microbiol | 2019 | https://conductscience.org/library/papers/30541939 | PubMed |
| 18 | 29326661 | En Route towards European Clinical Breakpoints for Veterinary Antimicrobial Susceptibility Testing: A Position Paper Explaining the VetCAST Approach. | Front Microbiol | 2017 | https://conductscience.org/library/papers/29326661 | PubMed |
| 19 | 32411113 | Population Biology and Epidemiological Studies of Acinetobacter baumannii in the Era of Whole Genome Sequencing: Is the Oxford Scheme Still Appropriate? | Front Microbiol | 2020 | https://conductscience.org/library/papers/32411113 | PubMed |
| 20 | 32284036 | Colistin and its role in the Era of antibiotic resistance: an extended review (2000-2019). | Emerg Microbes Infect | 2020 | https://conductscience.org/library/papers/32284036 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42268331 | Whole-genome characterization of a colistin-resistant Klebsiella quasipneumoniae subsp. quasipneumoniae isolate from a urinary tract infection in Peshawar, Pakistan. | Braz J Microbiol | 2026 | https://conductscience.org/library/papers/42268331 |
Source PubMed
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| HSPD1 | 3329 | PubTator's text mining | https://conductscience.org/library/genes/3329 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41892479
GET https://conductscience.org/api/papers/v1/41892479/references?page=2